At 3.15pm on Tuesday, London’s AIM Index was sitting almost eight points higher at 816.38, supported by a rebound in sentiment as the idea of the Federal Reserve taking a slightly more moderate approach bites.
- Trellus Health +41%
- Galantas Gold +32%
- Synairgen +14%
- Watkin Jones -34%
- Craven House -29%
Trellus Health LON:TRLS topped the board, with last night’s investor presentation perhaps bolstering sentiment here. Trades have been thin on the ground so far, but the stock is up 41%, comfortably eclipsing the 4.75% spread quoted at copy time.
Galantas Gold [LON:GAL] advanced 32% on the day. There’s no formal news out yet, but shares listed on Toronto jumped higher yesterday, so there’s some speculation that a production update could follow.
Synairgen LON:SNG gets the notable mention today, adding 14% off the back of news that its viral lung infection therapy was well tolerated and had reduced hospitalisation amongst COVID -19 patients,. However whilst encouraging, the results were deemed not to be statistically significant but warrant further investigation.
Watkins Jones LON:WJG was the day’s laggard, off 34% at copy time. A full year trading update this morning bid up a good story but concern over margin pressure going forward evidently took a toll, with FY’22 underlying operating profits being dialled down by 10%. The balance sheet is however reported as sound.
Craven House LON:CRV, with a market cap of arund £500k, is an absolute minnow of a firm. Today’s 29% slide left it in second to last place at 3.15pm, although trades were very limited and the spread is very wide. Nothing to see here, by all accounts.
